Literature DB >> 2936807

Immunoregulation of passively induced allergic encephalomyelitis.

D O Willenborg, P Sjollema, G Danta.   

Abstract

Experimental allergic encephalomyelitis (EAE) can be readily induced passively by transfer of lymphocytes from neuroantigen immunized rats to naive recipients. This passively induced disease runs an acute, monophasic, self-limiting course, much the same as is usually seen in actively induced diseases. Here we examine the mechanisms regulating passive EAE. We report that splenectomy, thymectomy, and increasing age of recipients, manipulations which have been reported to influence recovery from actively induced EAE, have no effect on passively induced disease. EAE effector cells are not inactivated when transferred into recipients that have been actively sensitized and are beginning their recovery from clinical signs; this being a time when recovery associated suppressor cells are thought to be present. Finally, in the absence of suppressor T cells in both the recipient and in the transfer cell population, recovery from passive EAE still occurs. We conclude that suppressor T cells play no role in regulating passively induced EAE.

Entities:  

Mesh:

Year:  1986        PMID: 2936807

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Kinetics of MHC gene expression and mRNA synthesis in brain endothelium.

Authors:  D Male; G Pryce
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

Review 2.  Immune surveillance of the central nervous system in multiple sclerosis--relevance for therapy and experimental models.

Authors:  Rehana Z Hussain; Liat Hayardeny; Petra C Cravens; Felix Yarovinsky; Todd N Eagar; Benjamine Arellano; Krystin Deason; Cyd Castro-Rojas; Olaf Stüve
Journal:  J Neuroimmunol       Date:  2014-08-30       Impact factor: 3.478

3.  Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids.

Authors:  I A MacPhee; F A Antoni; D W Mason
Journal:  J Exp Med       Date:  1989-02-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.